Combined use of aprotinin and a heparin-bonded cardiopulmonary bypass system for aortic aneurysm repair.

[1]  L. Edmunds.  Surface-bound heparin--panacea or peril? , 1994, The Annals of thoracic surgery.

[2]  M. Pasic,et al.  Risk and benefit of low systemic heparinization during open heart operations. , 1994, The Annals of thoracic surgery.

[3]  B. Nilsson,et al.  Complement activation during cardiopulmonary bypass: effects of immobilized heparin. , 1994, The Annals of thoracic surgery.

[4]  H. Teufelsbauer,et al.  Aprotinin does not decrease early graft patency after coronary artery bypass grafting despite reducing postoperative bleeding and use of donated blood. , 1994, The Journal of thoracic and cardiovascular surgery.

[5]  C. Tatooles,et al.  Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. A multicenter, randomized, double-blind, placebo-controlled study. , 1994, The Journal of thoracic and cardiovascular surgery.

[6]  G. Guiraudon,et al.  Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations. , 1994, The Journal of thoracic and cardiovascular surgery.

[7]  H. Philippou,et al.  Mechanisms of thrombin generation during surgery and cardiopulmonary bypass [see comments] , 1993 .

[8]  T. Treasure,et al.  Aprotinin therapy in cardiac operations: a report on use in 41 cardiac centers in the United Kingdom. , 1993, The Annals of thoracic surgery.

[9]  S. Westaby.  Aprotinin in perspective. , 1993, The Annals of thoracic surgery.

[10]  F. Loop,et al.  Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. , 1992, The Annals of thoracic surgery.

[11]  R. Karp,et al.  Monitoring of heparin-induced anticoagulation with kaolin-activated clotting time in cardiac surgical patients treated with aprotinin. , 1992, Anesthesiology.

[12]  B. Hunt,et al.  Aprotinin and Heparin Monitoring During Cardiopulmonary Bypass , 1992, Circulation.

[13]  W. Dietrich,et al.  High-dose aprotinin in cardiac surgery: three years' experience in 1,784 patients. , 1992, Journal of cardiothoracic and vascular anesthesia.

[14]  E. Fosse,et al.  Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. , 1992, The Journal of thoracic and cardiovascular surgery.

[15]  H. Hansson,et al.  Decreased blood loss after cardiopulmonary bypass using heparin-coated circuit and 50% reduction of heparin dose. , 1992, Scandinavian journal of thoracic and cardiovascular surgery.

[16]  L. V. von Segesser,et al.  Surgical treatment of cardiovascular complications in Marfan syndrome: a 27-year experience. , 1992, European Journal of Cardio-Thoracic Surgery.

[17]  C. T. Lewis,et al.  Surgical repair of aortic root aneurysms in 280 patients. , 1992, The Annals of thoracic surgery.

[18]  R. C. Dennis,et al.  Effect of graft material on loss of erythrocytes after aortic operations. , 1991, Surgery, gynecology & obstetrics.

[19]  M. Oppermann,et al.  Formation of C5a during cardiopulmonary bypass: inhibition by precoating with heparin. , 1991, The Annals of thoracic surgery.

[20]  W. van Oeveren,et al.  Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. , 1987, The Annals of thoracic surgery.